KOD
Kodiak Sciences Inc.
Key Financials
Operating Income
$-234388000
↓ 25.4%
Net Income
$-229967000
↓ 30.5%
Total Liabilities
$194.2M
↑ 4.8%
EPS (Diluted)
$-4.32
↓ 29.0%
Total Assets
$351.5M
↑ 4.8%
Cash & Equivalents
$209.9M
↑ 24.9%
Operating Cash Flow
$-136008000.00
↓ 15.9%
Shareholders' Equity
$157.4M
↑ 4.7%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| SCHEDULE 13G | 5/15/2026 | View on SEC |
| 10-Q | 5/7/2026 | View on SEC |
| 8-K | 5/7/2026 | View on SEC |
| SCHEDULE 13G | 4/27/2026 | View on SEC |
| ARS | 4/23/2026 | View on SEC |
| DEFA14A | 4/22/2026 | View on SEC |
| DEF 14A | 4/22/2026 | View on SEC |
| 4 | 4/16/2026 | View on SEC |
| 4 | 4/2/2026 | View on SEC |
| 144 | 4/2/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | KOD |
| Company Name | Kodiak Sciences Inc. |
| CIK | 1468748 |
| Sector | Biological Products, (No Diagnostic Substances) |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2836 |
| SIC Description | Biological Products, (No Diagnostic Substances) |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 650-281-0850 |